PTX3 and COVID-19: In conclusion, our data contribute to the accumulating evidence that PTX3 blood concentration may serve as an early marker of COVID-19 severity and support the need of larger, prospective studies that would hopefully pave the way to the use of PTX3 in the routine clinical practice.